Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17364-21-5

Post Buying Request

17364-21-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17364-21-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 17364-21-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,3,6 and 4 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 17364-21:
(7*1)+(6*7)+(5*3)+(4*6)+(3*4)+(2*2)+(1*1)=105
105 % 10 = 5
So 17364-21-5 is a valid CAS Registry Number.

17364-21-5Relevant articles and documents

Isolation and characterization of seven lyso platelet-activating factors and two lyso phosphatidylcholines from the crude drug 'Suitetsu' (the leech, Hirudo nipponica)

Noda,Tanaka,Nishi,Inoue,Miyahara

, p. 1366 - 1368 (1993)

Nine lyso glycerophospholipids were isolated in the pure state from the crude drug 'Suitetsu', which is the dried body of the leech, Hirudo nipponica (Hirudidae). They were identified as 1-O-hexadecyl-(1), 1-O-octadecyl-(2), 1- O-tetradecyl-(3), 1-O-9-cis-hexadecenyl-(4), 1-O-hexadecanoyl-(5), 1-O- pentadecyl-(6), 1-O-15-methylhexadecyl-(7), 1-O-octadecanoyl-(8) and 1-O- heptadecyl-sn-glycero-3-phosphocholine (9). Two of them (5 and 8) are lysophosphatidylcholines and the other seven are lyso platelet-activating factors. One of them has an alkenyl carbon chain.

Synthesis and antihypertensive activity of some 1-O-alkylglycero-3-phosphocholine derivatives

Noskov,Shishkov,Kruglyak,Kiselevskii,Dobryanskii,Maksimtseva,Sokal'skii

, p. 607 - 610 (1996)

-

Design, synthesis and cytotoxicity of chimeric erlotinib-alkylphospholipid hybrids

Alam, Md. Maqusood,Hassan, Ahmed H.E.,Lee, Kun Won,Cho, Min Chang,Yang, Ji Seul,Song, Jiho,Min, Kyung Hoon,Hong, Jongki,Kim, Dong-Hyun,Lee, Yong Sup

, p. 51 - 62 (2018/11/27)

Two series of erlotinib-alkylphospholipid hybrids were prepared and evaluated for their antiproliferative activities against a panel of four cell lines representing lung, breast, liver and skin cancers using erlotinib and miltefosine as reference standards. Amide analogs elicited more enhanced cytotoxic activity than analogous esters. Amide derivatives 8d and 8e exhibited promising broad-spectrum antiproliferative activity and higher efficacy than reference erlotinib and miltefosine. Their cellular GI50 values was in the ranges of 24.7–46.9 μM and 26.8–43.1 μM for 8e and 8d respectively. Assay results of the inhibitory activity of the prepared compounds on EGFR kinase reaction and Akt phosphorylation in conjugation with statistical correlation analysis indicated that other mechanisms might contribute to their elicited cytotoxicities. In addition, statistical correlation analysis revealed that mechanisms of elicited cytotoxicities for amide series might be different from ester series. In addition, correlation analysis indicated variations in the mechanisms according to the types of cell line.

Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue

Andresen, Thomas L.,Jensen, Simon S.,Madsen, Robert,J?rgensen, Kent

, p. 7305 - 7314 (2007/10/03)

The clinical use of anticancer lipids is severely limited by their ability to cause lysis of red blood cells prohibiting intravenous injection. Novel delivery systems are therefore required in order to develop anticancer ether lipids (AELs) into clinicall

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17364-21-5